CN Patent

CN101466384B — 包含促释剂的渗透递药系统

Assigned to Supernus Pharmaceuticals Inc · Expires 2015-04-22 · 11y expired

What this patent protects

本发明涉及口服渗透递药系统，其包含当在单室渗透泵递送系统中配制时显示不稳定或不完全释放曲线的高水溶性药物，以及至少一种促释剂。

USPTO Abstract

本发明涉及口服渗透递药系统，其包含当在单室渗透泵递送系统中配制时显示不稳定或不完全释放曲线的高水溶性药物，以及至少一种促释剂。

Drugs covered by this patent

treprostinil-diolamine (TREPROSTINIL DIOLAMINE)

Patent Metadata

Patent number: CN101466384B
Jurisdiction: CN
Classification: —
Expires: 2015-04-22
Drug substance claim: No
Drug product claim: No
Assignee: Supernus Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.